Natural products: A continuing source of novel drug leads
Tóm tắt
Từ khóa
Tài liệu tham khảo
Borchardt, 2002, The beginnings of drug therapy: Ancient mesopotamian medicine, Drug News Perspect., 15, 187, 10.1358/dnp.2002.15.3.840015
Huang, 1999
Kapoor, 1990
Dev, 1999, Ancient-modern concordance in ayurvedic plants: Some examples, Environ. Health Perspect., 107, 783, 10.1289/ehp.99107783
Moerman, 1986
Johnson, 1999
Farnsworth, 1985, Medicinal plants in therapy, Bull. World Health Organ., 63, 965
Fabricant, 2001, The value of plants used in traditional medicine for drug discovery, Environ. Health Perspect., 109, 69, 10.1289/ehp.01109s169
Buss, 1995, Natural products as leads for new pharmaceuticals, vol. 1, 983
Wongsrichanalai, 2002, Epidemiology of drug-resistant malaria, Lancet Infect. Dis., 2, 209, 10.1016/S1473-3099(02)00239-6
Klayman, 1985, Isolation of artemisinin (qinghaosu) from artemisia annua growing in the United States, J. Nat. Prod., 47, 715, 10.1021/np50034a027
Klayman, 1985, Qinghaosu (artemisinin): An antimalarial drug from China, Science, 228, 1049, 10.1126/science.3887571
Miller, 2011, Atermisinin: Discovery from the Chinese herbal garden, Cell, 146, 855, 10.1016/j.cell.2011.08.024
O'Neill, 2004, A medicinal chemistry perspective on artemisinin and related endoperoxides, J. Med. Chem., 47, 2945, 10.1021/jm030571c
O'Neill, 2010, The molecular mechanism of action of artemisinin - the debate continues, Molecules, 15, 1705, 10.3390/molecules15031705
Wang, 2010, Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation, PLoS One, 5, e9582, 10.1371/journal.pone.0009582
Vennerstrom, 2004, Identification of an antimalarial synthetic trioxolane drug development candidate, Nature, 430, 900, 10.1038/nature02779
Posner, 2007, Malaria-infected mice are cured by a single dose of novel artemisinin derivatives, J. Med. Chem., 50, 2516, 10.1021/jm070149m
Cordell, 2012, Natural products and traditional medicine: Turning on a paradigm, J. Nat. Prod., 75, 514, 10.1021/np200803m
Hartwell, 1982
Cragg, 1994, Ethnobotany and drug discovery: The experience of the US National Cancer Institute, vol. 185, 178
Gueritte, 2005, The vinca alkaloids, 123
Roussi, 2012, The vinca alkaloids, 177
Lee, 2005, Podophyllotoxin and analogs, 71
Lee, 2012, Podophyllotoxin and analogs, 95
Kingston, 2005, Taxol and its analogs, 89
Kingston, 2012, Taxol and its analogs, 123
Schiff, 1980, Taxol stabilizes microtubules in mouse fibroblast cells, Proc. Natl. Acad. Sci. U. S. A., 77, 1561, 10.1073/pnas.77.3.1561
Green, 2006, Abraxane, a novel cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer, Ann. Oncol., 17, 1263, 10.1093/annonc/mdl104
A.C. Burman, R. Mukherjee, D. Khattar, M. Kumar, H. Bala, R.K. Shrivastava, Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles, in: Patent EP 1216042, 12JUN2000.
Kingston, 2007, Taxoids: Cancer-fighting compounds from nature, Curr. Opin. Drug Discov. Dev., 10, 130
Rahier, 2005, Camptothecin and its analogs, 5
Kirschning, 2008, The chemistry and biology of the maytansinoid antitumor agents, C. R. Chimie, 11, 1523, 10.1016/j.crci.2008.02.006
Yu, 2012, Ansamitocins (maytansenoids), 407
Senter, 2009, Potent antibody drug conjugates for cancer therapy, Curr. Opin. Chem. Biol., 13, 235, 10.1016/j.cbpa.2009.03.023
Alley, 2010, Antibody-drug conjugates: Targeted drug delivery for cancer, Curr. Opin. Chem. Biol., 14, 529, 10.1016/j.cbpa.2010.06.170
Caravella, 2010, Design of next-generation protein therapeutics, Curr. Opin. Chem. Biol., 14, 520, 10.1016/j.cbpa.2010.06.175
Lambert, 2010, Antibody-maytansinoid conjugates: A new strategy for the trreatment of cancer, Drugs Future, 35, 471, 10.1358/dof.2010.035.06.1497487
Kümler, 2011, Trastuzumab emtansine: Tumor-activated prodrug (tap) immunoconjugate oncolytic, Drugs Future, 36, 825, 10.1358/dof.2011.036.11.1711891
Margulis, 1988
Newman, 2004, Marine natural products and related compounds in clinical and advanced preclinical trials, J. Nat. Prod., 67, 1216, 10.1021/np040031y
Gerwick, 2012, Lessons from the past and charting the future of marine natural products drug discovery and chemical biology, Chem. Biol., 19, 85, 10.1016/j.chembiol.2011.12.014
Wallace, 2006, Ziconotide: A new nonopioid intrathecal analgesic for the treatment of chronic pain, Expert Rev. Neurother., 6, 1423, 10.1586/14737175.6.10.1423
Bulaj, 2003, Efficient oxidative folding of conotoxins and the radiation of venomous cone snails, Proc. Natl. Acad. Sci. U. S. A., 100, 14562, 10.1073/pnas.2335845100
Clark, 2012, Cyclization of conotoxins to improve their biopharmaceutical properties, Toxicon, 59, 446, 10.1016/j.toxicon.2010.12.003
Henriquez, 2005, Ecteinascidin 743 (et-743); Yondelis™, Aplidin and Kahalalide F, 215
Cuevas, 2009, Development of Yondelis® (trabectedin, et-743). A semisynthetic process solves the supply problem, Nat. Prod. Rep., 26, 322, 10.1039/b808331m
Cuevas, 2012, Ecteinascidin-743 (Yondelis(r)), Aplidine(r), and Irvalec(r), 291
Rath, 2011, Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product et-743, ACS Chem. Biol., 6, 1244, 10.1021/cb200244t
Yu, 2005, Discovery of e7389, a fully synthetic macrocyclic ketone analog of halichondrin b, 241
Newman, 2005, The bryostatins, 137
Newman, 2012, The bryostatins, 199
Yu, 2011, Case history: Discovery of eribulin (halaven™), a halichondrin b analogue that prolongs overall survival in patients with metastatic breast cancer, vol. 46, 227
Cortes, 2011, Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (embrace): A phase 3 open-label randomised study, Lancet, 377, 914, 10.1016/S0140-6736(11)60070-6
Morgan, 2012, Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: A California cancer consortium study, Invest. New Drugs, 30, 723, 10.1007/s10637-010-9557-5
Scriabine, 1999, Discovery and development of major drugs currently in use, 148
Arcamone, 2005, Anthracyclines, 299
Arcamone, 2012, Anthracyclines, 383
Hecht, 2005, Bleomycin group antitumor agents, 357
Hecht, 2012, Bleomycin group antitumor agents, 451
Remers, 2005, The mitomycins, 475
Hamann, 2005, Enediynes, 451
Hamann, 2012, Enediynes, 575
Prudhomme, 2005, Staurosporines and structurally related indolocarbazoles as antitumor agents, 499
Prudhomme, 2012, Staurosporines and structurally related indolocarbazoles as antitumor agents, 647
Knolker, 2008, Chemistry and biology of the carbazole alkaloids, vol. 65, 1
Nakano, 2009, Chemical biology of natural indolocarbazole products: 30years since the discovery of staurosporine, J. Antibiot., 62, 17, 10.1038/ja.2008.4
Hofle, 2005, Epothilone, a myxobacterial metabolite with promising antitumor activity, 413
Hofle, 2012, Epothilone, a myxobacterial metabolite with promising antitumor activity, 513
Wilson, 2006, Small molecule natural products in the discovery of therapeutic agents: The synthesis connection, J. Org. Chem., 71, 8329, 10.1021/jo0610053
Altmann, 2007, Anticancer drugs from nature-natural products as a unique source of new microtubule-stabilizing agents, Nat. Prod. Rep., 24, 327, 10.1039/B515619J
Altmann, 2007, The chemistry and biology of epothilones - the wheel keeps turning, ChemMedChem, 2, 396, 10.1002/cmdc.200600206
Tse, 2007, Substrate tolerance of module 6 of the epothilone synthase, Biochemistry, 46, 3385, 10.1021/bi0616448
Chi, 2012, A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian urologic oncology group study p07a, Ann. Oncol., 23, 53, 10.1093/annonc/mdr336
McMeekin, 2012, Phase i/ii study of sagopilone (zk-epo) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer, Br. J. Cancer, 106, 70, 10.1038/bjc.2011.499
Klar, 2006, Total synthesis and antitumor activity of zk-epo: The first fully synthetic epothilone in clinical development, Angew. Chem. Int. Ed., 45
Nix, 2009, Pharmacokinetics of nikkomycin z after single rising oral doses, Antimicrob. Agents Chemother., 53, 2517, 10.1128/AAC.01609-08
Debono, 1994, Antibiotics that inhibit fungal cell wall development, Annu. Rev. Microbiol., 48, 471, 10.1146/annurev.mi.48.100194.002351
Georgopapadakou, 1995, The fungal cell wall as a drug target, Trends Microbiol., 3, 98, 10.1016/S0966-842X(00)88890-3
Debono, 1995, Semisynthetic chemical modification of the antifungal lipopeptide echinocandin b (ecb): Structure-activity studies of the lipophilic and geometric parameters of polyarylated acyl analogs of ecb, J. Med. Chem., 38, 3271, 10.1021/jm00017a012
Schwartz, 1992, Pneumocandins from Zalerion arboricola I. Discovery and isolation, J. Antibiot., 45, 1853, 10.7164/antibiotics.45.1853
Masurekar, 1992, Pneumocandins from Zalerion arboricola II. Modification of product spectrum by mutation and medium manipulation, J. Antibiot., 45, 1867, 10.7164/antibiotics.45.1867
Schmatz, 1992, Pneumocandins from Zalerion arboricola IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species, J. Antibiot., 45, 1886, 10.7164/antibiotics.45.1886
Bartizal, 1992, In vitro antifungal activities and in vivo efficacies of 1,3-beta-d-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin b, and L-687,781, a papulacandin, Antimicrob. Agents Chemother., 36, 1648, 10.1128/AAC.36.8.1648
Kurtz, 2001, Glucan synthase inhibitors as antifungal agents, Adv. Protein Chem., 36, 423, 10.1016/S0065-3233(01)56011-8
Mohr, 2008, Current options in antifungal pharmacotherapy, Pharmacotherapy, 28, 614, 10.1592/phco.28.5.614
Pitman, 2011, Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations, Exp. Opin. Emerging Drugs, 16, 559, 10.1517/14728214.2011.607811
Roemer, 2011, Confronting the challenges of natural product-based antifungal discovery, Chem. Biol., 18, 148, 10.1016/j.chembiol.2011.01.009
Ingham, 2012, Microcolony imaging of Aspergillus fumigatus treated with echinocandins reveals both fungistatic and fungicidal activities, PLoS One, 7, e35478, 10.1371/journal.pone.0035478
Daly, 2005, Alkaloids from amphibian skins. A tabulation of over eight hundred compounds, J. Nat. Prod., 68, 1556, 10.1021/np0580560
Eng, 1992, Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspecturn venom, J. Biol. Chem., 267, 7402, 10.1016/S0021-9258(18)42531-8
Newman, 2012, Natural products as sources of new drugs over the 30years from 1981 to 2010, J. Nat. Prod., 75, 311, 10.1021/np200906s
Wilson, 2006, Applications of total synthesis to problems in neurodegeneration: Fascinating chemistry along the way, Acc. Chem. Res., 39, 539, 10.1021/ar068018n
Meijer, 2003, Le cycle de division cellulaire et sa regulation, Oncologie, 5, 311
Cragg, 2006, Natural product sources of drugs: Plants, microbes, marine organisms and animals, vol. 1, 355
Balandrin, 1993, Plant-derived natural products in drug discovery and development, vol. 534, 2
Raskin, 2002, Plants and human health in the twenty-first century, Trends Biotechnol., 20, 522, 10.1016/S0167-7799(02)02080-2
Newman, 2006, New drugs from marine microbes: The tide is turning, J. Ind. Microbiol. Biotechnol., 33, 539, 10.1007/s10295-006-0115-2
Perry, 1994, Alkaloids from the Antarctic sponge Kirkpatrickia varialosa. : Part 1: Variolin B, a new antitumour and antiviral compound., Tetrahedron, 50, 3987, 10.1016/S0040-4020(01)89673-3
Trimurtulu, 1994, Alkaloids from the Antarctic sponge Kirkpatrickia varialosa. Part 2: Variolin a and n(3′)-methyl tetrahydrovariolin B, Tetrahedron, 50, 3993, 10.1016/S0040-4020(01)89674-5
Ahaidar, 2003, Total syntheses of variolin B and deoxyvariolin B, J. Org. Chem., 68, 10020, 10.1021/jo035332b
Diyabalanage, 2006, Palmerolide A, a cytotoxic macrolide from the Antarctic tunicate Synoicum adareanum, J. Am. Chem. Soc., 128, 5630, 10.1021/ja0588508
Nicolaou, 2007, Synthesis of the originally proposed and revised structures of palmerolide A, Angew. Chem. Int. Ed., 46, 5896, 10.1002/anie.200702243
Wilson, 2009, Molecules derived from the extremes of life, Nat. Prod. Rep., 26, 44, 10.1039/B800164M
Poulev, 2003, Elicitation, a new window into plant chemodiversity and phytochemical drug discovery, J. Med. Chem., 2542, 10.1021/jm020359t
McCoy, 2006, Directed biosynthesis of alkaloid analogs in the medicinal plant Catharanthus roseus, J. Am. Chem. Soc., 128, 14276, 10.1021/ja066787w
Maresh, 2008, Strictosidine synthase: Mechanism of a Pictet-Spengler catalyzing enzyme, J. Am. Chem. Soc., 130, 710, 10.1021/ja077190z
McCoy, 2008, Natural products from plant cell cultures, Prog. Drug Res., 65, 330
Giddings, 2011, A stereoselective hydroxylation step of alkaloid biosynthesis by a unique cytochrome p450 in Catharanthus roseus, J. Biol. Chem., 286, 16751, 10.1074/jbc.M111.225383
Liscombe, 2011, A virus-induced gene silencing approach to understanding alkaloid metabolism in Catharanthus roseus, Phytochemistry, 72, 1969, 10.1016/j.phytochem.2011.07.001
Xu, 2011, Unusual withanolides from aeroponically grown Withania somnifera, Phytochemistry, 72, 518, 10.1016/j.phytochem.2010.12.020
Pace, 1997, A molecular view of microbial diversity and the biosphere, Science, 276, 734, 10.1126/science.276.5313.734
Madigan, 1996
McAlpine, 2005, Microbial genomics as a guide to drug discovery and structural elucidation: Eco-02301, a novel antifungal agent, as an example, J. Nat. Prod., 68, 493, 10.1021/np0401664
Lautru, 2005, Discovery of a new peptide natural product by Streptomyces coelicolor genome mining, Nat. Chem. Biol., 1, 265, 10.1038/nchembio731
Zengler, 2002, Cultivating the uncultured, Proc. Natl. Acad. Sci. U. S. A., 99, 15681, 10.1073/pnas.252630999
Udwary, 2007, Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica, Proc. Natl. Acad. Sci. U. S. A., 104, 10376, 10.1073/pnas.0700962104
Nett, 2009, Genomic basis for natural product biosynthetic diversity in the actinomycetes, Nat. Prod. Rep., 26, 1362, 10.1039/b817069j
Gontang, 2007, Phylogenetic diversity of Gram-positive bacteria cultured from marine sediments, Appl. Environ. Microbiol., 73, 3272, 10.1128/AEM.02811-06
Sanchez, 2012, Advances in Aspergillus secondary metabolite research in the post-genomic era, Nat. Prod. Rep., 29, 351, 10.1039/c2np00084a
Rondon, 2000, Cloning the soil metagenome: A strategy for accessing the genetic and functional diversity of uncultured microorganisms, Appl. Environ. Microbiol., 66, 2541, 10.1128/AEM.66.6.2541-2547.2000
Venter, 2004, Environmental genome shotgun sequencing of the Sargasso sea, Science, 304, 66, 10.1126/science.1093857
Brady, 2009, Metagenomic approaches to natural products from free-living and symbiotic organisms, Nat. Prod. Rep., 26, 1488, 10.1039/b817078a
Yooseph, 2007, The Sorcerer II global ocean sampling expedition: Expanding the universe of protein families, PLoS Biol., 5, e16, 10.1371/journal.pbio.0050016
Crawford, 2012, Microbial genome mining answers longstanding biosynthetic questions, Proc. Natl. Acad. Sci. U. S. A., 109, 7589, 10.1073/pnas.1205361109
Zimmermann, 2009, Pederin-type pathways of uncultivated bacterial symbionts: Analysis of o-methyltransferases and generation of a biosynthetic hybrid, J. Am. Chem. Soc., 131, 2780, 10.1021/ja808889k
Jin, 2003, Structural and functional analysis of pantocin A: An antibiotic from Pantoea agglomerans discovered by heterologous expression of cloned genes, Angew. Chem. Int. Ed., 42, 2898, 10.1002/anie.200351053
Abe, 2001, The biotechnological potential of piezophiles, Trends Biotechnol., 19, 102, 10.1016/S0167-7799(00)01539-0
Amato, 2006, Microbes live near undersea CO2 lake, Chem. Eng. News, 84, 14, 10.1021/cen-v084n038.p014
Cavicchioli, 2002, Low-temperature extremophiles and their applications, Curr. Opin. Biotechnol., 13, 253, 10.1016/S0958-1669(02)00317-8
Schiraldi, 2002, The production of biocatalysts and biomolecules from extremophiles, Trends Biotechnol., 20, 515, 10.1016/S0167-7799(02)02073-5
van den Burg, 2003, Extremophiles as a source for novel enzymes, Curr. Opin. Microbiol., 6, 213, 10.1016/S1369-5274(03)00060-2
Gomes, 2004, The biocatalytic potential of extremophiles and extremozymes, Food Technol. Biotechnol., 42, 223
Hoyoux, 2004, Extreme catalysts from low-temperature environments, J. Biosci. Bioeng., 98, 317, 10.1016/S1389-1723(04)00290-7
Johnson, 2003, The microbiology of acidic mine waters, Res. Microbiol., 154, 466, 10.1016/S0923-2508(03)00114-1
Stierle, 2004, Novel sesquiterpenoid matrix metalloproteinase-3 inhibitors from an acid mine waste extremophile, J. Nat. Prod., 67, 1392, 10.1021/np049975d
Stierle, 2004, Berkeleydione and berkeleytrione, new bioactive metabolites from an acid mine organism, Org. Lett., 6, 1049, 10.1021/ol049852k
Stierle, 2005, Bioprospecting in the Berkeley pit: Bioactive metabolites from acid mine waste extremophiles, Stud. Nat. Prod. Chem., 32, 1123, 10.1016/S1572-5995(05)80074-2
Stierle, 2011, Berkeleyones and related meroterpenes from a deep water acid mine waste fungus that inhibit the production of interleukin 1-β from induced inflammasomes, J. Nat. Prod., 74, 2273, 10.1021/np2003066
Tan, 2001, Endophytes: A rich source of functional metabolites, Nat. Prod. Rep., 18, 448, 10.1039/b100918o
Strobel, 2004, Natural products from endophytic microorganisms, J. Nat. Prod., 67, 257, 10.1021/np030397v
Gunatilaka, 2006, Natural products from plant-associated microorganisms: Distribution, structural diversity, bioactivity, and implications of their occurrence, J. Nat. Prod., 69, 509, 10.1021/np058128n
Castillo, 2003, Kakadumycins, novel antibiotics from Streptomyces sp. NRRL 30566, an endophyte of Grevillea pteridifolia, FEMS Microbiol. Lett., 224, 183, 10.1016/S0378-1097(03)00426-9
Li, 2001, Ambuic acid, a highly functionalized cyclohexenone with antifungal activity from Pestalotiopsis spp. and Monochaetia sp, Phytochemistry, 56, 463, 10.1016/S0031-9422(00)00408-8
Zhou, 2004, Aspochalasins i, j, and k: Three new cytotoxic cytochalasans of Aspergillus flavipes from the rhizosphere of Ericameria laricifolia of the sonoran desert, J. Nat. Prod., 67, 328, 10.1021/np030353m
Stierle, 1993, Taxol and taxane production by Taxomyces andreanae, an endophytic fungus of pacific yew, Science, 260, 214, 10.1126/science.8097061
Li, 1998, Stimulation of taxol production in liquid cultures of Pestalotiopsis microspora, Mycol. Res., 102, 461, 10.1017/S0953756297005078
Puri, 2005, An endophytic fungus from Nothapodytes foetida that produces camptothecin, J. Nat. Prod., 68, 1717, 10.1021/np0502802
Amna, 2006, Bioreactor studies on the endophytic fungus Entrophosphora infrequens for the production of an anticancer alkaloid camptothecin, Can. J. Microbiol., 52, 189, 10.1139/W05-122
Eyberger, 2006, Endophyte fungal isolates from Podophyllum peltatum produce podophyllotoxin, J. Nat. Prod., 69, 1121, 10.1021/np060174f
Puri, 2006, The endophytic fungus Trametes hirsuta as a novel alternative source of podophyllotoxin and related tetralin lignans, J. Biotechnol., 122, 494, 10.1016/j.jbiotec.2005.10.015
Guo, 1998, Isolation of a fungus producing vinblastine, J. Yunnan Univ., 20, 214
Zhang, 2000, Preliminary study on the isolation of endophytic fungus of Catharanthus roseus and its fermentation to produce products of therapeutic value, Zhong Cao Yao (Chinese Tradit. Herb. Drugs), 31, 805
Yang, 2004, Preliminary study of a vincristine-producing endophytic fungus isolated from leaves of Catharanthus roseus, Zhong Cao Yao (Chinese Tradit. Herb. Drugs), 35, 79
Bok, 2006, Genomic mining for Aspergillus natural products, Chem. Biol., 13, 31, 10.1016/j.chembiol.2005.10.008
Hoffmeister, 2007, Natural products of filamentous fungi: Enzymes, genes, and their regulation, Nat. Prod. Rep., 24, 393, 10.1039/B603084J
Mincer, 2002, Widespread and persistent populations of a major new marine Actinomycete taxon in ocean sediments, Appl. Environ. Microbiol., 68, 5005, 10.1128/AEM.68.10.5005-5011.2002
Feling, 2003, Salinosporamide A: A highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora, Angew. Chem. Int. Ed., 42, 355, 10.1002/anie.200390115
Kwon, 2006, Marinomycins A-D, antitumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus "Marinispora", J. Am. Chem. Soc., 128, 1622, 10.1021/ja0558948
Williams, 2007, Saliniketals A and B, bicyclic polyketides from the marine actinomycete Salinispora arenicola, J. Nat. Prod., 70, 83, 10.1021/np0604580
Oh, 2007, Thalassospiramides A and B, immunosuppressive peptides from the marine bacterium Thalassopira sp, Org. Lett., 9, 1525, 10.1021/ol070294u
Waters, 2010, The expanding role of marine microbes in pharmaceutical development, Curr. Opin. Biotechnol., 21, 780, 10.1016/j.copbio.2010.09.013
Pettit, 2011, Culturability and secondary metabolite diversity of extreme microbes: Expanding contribution of deep sea and deep-sea vent microbes to natural product discovery, Mar. Biotechnol., 13, 1, 10.1007/s10126-010-9294-y
Piel, 2005, Exploring the chemistry of uncultivated bacterial symbionts: Antitumor polyketides of the pederin family, J. Nat. Prod., 68, 472, 10.1021/np049612d
Piel, 2004, Evidence for a symbiosis island involved in horizontal acquisition of pederin biosynthetic capabilities by the bacterial symbiont of Paederus fuscipes beetles, J. Bacteriol., 186, 1280, 10.1128/JB.186.5.1280-1286.2004
Piel, 2004, Antitumor polyketide biosynthesis by an uncultivated bacterial symbiont of the marine sponge Theonella swinhoei, Proc. Natl. Acad. Sci. U. S. A., 101, 16222, 10.1073/pnas.0405976101
Radjasa, 2011, Highlights of marine invertebrate-derived biosynthetic products: Their biomedical potential and possible production by microbial associants, Bioorg. Med. Chem., 19, 6658, 10.1016/j.bmc.2011.07.017
Partida-Martinez, 2005, Pathogenic fungus harbours endosymbiotic bacteria for toxin production, Nature, 437, 884, 10.1038/nature03997
Partida-Martinez, 2007, Rhizonin, the first mycotoxin isolated from the zygomycota, is not a fungal metabolite but is produced by bacterial endosymbionts, Appl. Environ. Microbiol., 73, 793, 10.1128/AEM.01784-06
Partida-Martinez, 2007, Burkholderia rhizoxinica sp. nov. and Burkholderia endofungorum sp. nov., bacterial endosymbionts of the plant-pathogenic fungus Rhizopus microsporous, Int. J. Syst. Evol. Microbiol., 57, 2583, 10.1099/ijs.0.64660-0
Lackner, 2009, Global distribution and evolution of a toxinogenic Burkholderia-Rhizopus symbiosis, Appl. Environ. Microbiol., 75, 2982, 10.1128/AEM.01765-08
Khosla, 2000, Natural product biosynthesis: A new interface between enzymology and medicine, J. Org. Chem., 65, 8127, 10.1021/jo000849y
Staunton, 2001, Polyketide biosynthesis: A millennium review, Nat. Prod. Rep., 18, 380, 10.1039/a909079g
Walsh, 2004, Polyketide and nonribosomal peptide antibiotics: Modularity and versatility, Science, 303, 1805, 10.1126/science.1094318
Walsh, 2007, The chemical versatility of natural-product assembly lines, Acc. Chem. Res., 41, 4, 10.1021/ar7000414
Van Lanen, 2012, Combinatorial biosynthesis of anticancer natural products, 671
Julien, 2000, Isolation and characterization of the epothilone biosynthetic gene cluster from Sorangium cellulosum, Gene, 249, 153, 10.1016/S0378-1119(00)00149-9
Molnar, 2000, The biosynthetic gene cluster for the microtubule-stabilizing agents epothilones A and B from Sorangium cellulosum so ce90, Chem. Biol., 7, 97, 10.1016/S1074-5521(00)00075-2
Lau, 2002, Optimizing the heterologous production of epothilone D in Myxococcus xanthus, Biotechnol. Bioeng., 78, 280, 10.1002/bit.10202
Nicolaou, 2000, The art and science of total synthesis at the dawn of the twenty-first century, Angew. Chem. Int. Ed., 39, 44, 10.1002/(SICI)1521-3773(20000103)39:1<44::AID-ANIE44>3.0.CO;2-L
Li, 2001, Total synthesis of nominal diazonamides - part 2: On the true structure and origin of natural isolates, Angew. Chem. Int. Ed., 40, 4770, 10.1002/1521-3773(20011217)40:24<4770::AID-ANIE4770>3.0.CO;2-T
Freemantle, 2004, Scaled-up synthesis of discodermolide, Chem. Eng. News, 82, 33, 10.1021/cen-v082n009.p033
Mickel, 2004, Large-scale synthesis of the anti-cancer marine natural product (+)-discodermolide. Part 5: Linkage of fragments c1-6 and c7-24 and finale., Org. Process Res. Dev., 8, 122, 10.1021/op034134j
Singh, 2011, Structure-activity studies of the pelorusides: New congeners and semi-synthetic analogues, Org. Biomol. Chem., 9, 4456, 10.1039/c0ob01127d
Paterson, 2011, Total synthesis and biological evaluation of a series of macrocyclic hybrids and analogues of the antimitotic natural products dictyostatin, discodermolide, and taxol, Chem. Asian J., 6, 459, 10.1002/asia.201000541
Dalby, 2010, Synthesis of polyketide natural products and analogs as promising anticancer agents, Curr. Opin. Drug Discov. Dev., 13, 777
Smith, 2009, Spongipyran synthetic studies. Evolution of a scalable total synthesis of (+)-spongistatin 1, Tetrahedron, 65, 6489, 10.1016/j.tet.2009.04.003
Seiple, 2010, Total synthesis of palau'amine, Angew. Chem. Int. Ed., 49, 1095, 10.1002/anie.200907112
Nicolaou, 1998, Synthesis and biological activity of sarcodictyins, Angew. Chem. Int. Ed., 37, 1418, 10.1002/(SICI)1521-3773(19980605)37:10<1418::AID-ANIE1418>3.0.CO;2-5
Evans, 1988, Methods for drug discovery: Development of potent, selective, orally effective cholecystokinin antagonists, J. Med. Chem., 2235, 10.1021/jm00120a002
Koch, 2005, Protein structure similarity clustering and natural product structure as guiding principles in drug discovery, Drug Discov. Today, 10, 471, 10.1016/S1359-6446(05)03419-7
Nicolaou, 2000, Natural product-like combinatorial libraries based on privileged structures. 1. General principles and solid-phase synthesis of benzopyrans, J. Am. Chem. Soc., 122, 9939, 10.1021/ja002033k
Nicolaou, 2000, Natural product-like combinatorial libraries based on privileged structures. 3. The "libraries from libraries" principle for diversity enhancement of benzopyran libraries, J. Am. Chem. Soc., 122, 9968, 10.1021/ja0020355
Nicolaou, 2000, Natural product-like combinatorial libraries based on privileged structures. 2. Construction of a 10 000-membered benzopyran library by directed split-and-pool chemistry using nanokans and optical encoding, J. Am. Chem. Soc., 122, 9954, 10.1021/ja002034c
Borman, 2003, The many faces of combinatorial chemistry, Chem. Eng. News, 81, 45, 10.1021/cen-v081n043.p045
Borman, 2004, Rescuing combichem. Diversity-oriented synthesis (dos) aims to pick up where traditional combinatorial chemistry left off., Chem. Eng. News, 82, 32, 10.1021/cen-v082n040.p032
Cragg, 2009, Impact of natural products on developing new anti-cancer agents, Chem. Rev., 109, 3012, 10.1021/cr900019j
Eberhardt, 2011, Exploring and exploiting biologically relevant chemical space, Curr. Drug Targets, 12, 1531, 10.2174/138945011798109482
Burke, 2003, Generating diverse skeletons of small molecules combinatorially, Science, 302, 613, 10.1126/science.1089946
Burke, 2004, A planning strategy for diversity-oriented synthesis, Angew. Chem. Int. Ed., 43, 46, 10.1002/anie.200300626
Breinbauer, 2002, Natural product guided compound library development, Curr. Med. Chem., 9, 2129, 10.2174/0929867023368773
Breinbauer, 2002, From protein domains to drug candidates—natural products as guiding principles in the design and synthesis of compound libraries, Angew. Chem. Int. Ed., 41, 2878, 10.1002/1521-3773(20020816)41:16<2878::AID-ANIE2878>3.0.CO;2-B
Brohm, 2002, Natural products are biologically validated starting points in structural space for compound library development: Solid-phase synthesis of dysidiolide-derived phosphatase inhibitors, Angew. Chem. Int. Ed., 41, 307, 10.1002/1521-3773(20020118)41:2<307::AID-ANIE307>3.0.CO;2-1
Ganesan, 2004, Natural products as a hunting ground for combinatorial chemistry, Curr. Opin. Biotechnol., 15, 584, 10.1016/j.copbio.2004.09.002
Stahl, 2002, Natural product derived receptor tyrosine kinase inhibitors: Identification of igf1r, tie-2, and vegfr-3 inhibitors, Angew. Chem. Int. Ed., 41, 1174, 10.1002/1521-3773(20020402)41:7<1174::AID-ANIE1174>3.0.CO;2-V
Thutewohl, 2002, Solid-phase synthesis and biological evaluation of a pepticinnamin E library, Angew. Chem. Int. Ed., 41, 3616, 10.1002/1521-3773(20021004)41:19<3616::AID-ANIE3616>3.0.CO;2-F
Ganesan, 2008, The impact of natural products upon modern drug discovery, Curr. Opin. Chem. Biol., 12, 306, 10.1016/j.cbpa.2008.03.016
Kopp, 2012, A diversity-oriented synthesis approach to macrocycles via oxidative ring expansion, Nat. Chem. Biol., 8, 358, 10.1038/nchembio.911
Camp, 2012, Drug-like properties: Guiding principles for the design of natural product libraries, J. Nat. Prod., 75, 72, 10.1021/np200687v
Bode, 2005, The impact of bacterial genomics on natural product research, Angew. Chem. Int. Ed., 44, 6828, 10.1002/anie.200501080
Yadav, 2009, Towards prediction of metabolic products of polyketide synthases: An in silico analysis, PLoS Comput. Biol., 5, e1000351, 10.1371/journal.pcbi.1000351
Lane, 2011, A sea of biosynthesis: Marine natural products meet the molecular age, Nat. Prod. Rep., 28, 411, 10.1039/C0NP90032J
Akey, 2012, Insights from the sea: Structural biology of marine polyketide synthases, Nat. Prod. Rep., 29, 1038, 10.1039/c2np20016c
Banskota, 2006, Genomic analyses lead to novel secondary metabolites. Part 3. Eco-0501, a novel antibacterial of a new class, J. Antibiot., 59, 533, 10.1038/ja.2006.74
Clardy, 2006, New antibiotics from bacterial natural products, Nat. Biotechnol., 24, 1541, 10.1038/nbt1266
Lam, 2007, New aspects of natural products in drug discovery, Trends Microbiol., 15, 279, 10.1016/j.tim.2007.04.001
Rachid, 2007, Deciphering regulatory mechanisms for secondary metabolite production in the myxobacterium Sorangium cellulosum so ce56, Mol. Microbiol., 63, 1783, 10.1111/j.1365-2958.2007.05627.x
Herrmann, 2012, Pretubulysin: From hypothetical biosynthetic intermediate to potential lead in tumor therapy, PLoS One, 7, e37416, 10.1371/journal.pone.0037416
Wang, 2006, Platensimycin is a selective fabf inhibitor with potent antibiotic properties, Nature, 441, 358, 10.1038/nature04784
Jayasuriya, 2007, Isolation and structure of platencin: A fabh and fabf dual inhibitor with potent broad-spectrum antibiotic activity, Angew. Chem. Int. Ed., 4684, 10.1002/anie.200701058
Young, 2006, Discovery of fabh/fabf inhibitors from natural products, Antimicrob. Agents Chemother., 50, 519, 10.1128/AAC.50.2.519-526.2006
Singh, 2006, Discovery of lucensimycins A and B from Streptomyces lucensis ma7349 using an antisense strategy, Org. Lett., 8, 5449, 10.1021/ol062041r
Nicolaou, 2006, Total synthesis of platensimycin, Angew. Chem. Int. Ed., 45, 7086, 10.1002/anie.200603892
Nicolaou, 2007, Asymmetric total syntheses of platensimycin, Angew. Chem. Int. Ed., 46, 3942, 10.1002/anie.200700586
Nicolaou, 2007, Adamanta-platensimycin: A bioactive analogue of platensimycin, Angew. Chem. Int. Ed., 46, 4712, 10.1002/anie.200701548
Zhang, 2011, Platensimycin and platencin congeners from Streptomyces platensis, J. Nat. Prod., 74, 329, 10.1021/np100635f
Cragg, 2012, Legal and ethical issues involving marine biodiscovery and development, vol. 2, 1316
Cragg, 2012, The impact of the united nations convention on biological diversity on natural products research, Nat. Prod. Rep., 29, 1407, 10.1039/c2np20091k
Payne, 2007, Drugs for bad bugs: Confronting the challenges of antibacterial discovery, Nat. Rev. Drug Discov., 6, 29, 10.1038/nrd2201
Macarron, 2011, Impact of high-throughput screening in biomedical research, Nat. Rev. Drug Discov., 10, 188, 10.1038/nrd3368
Suffness, 1989, Discovery and development of antineoplastic agents from natural sources, vol. 3, 132
Sin, 1999, Total synthesis of the potent proteasome inhibitor epoximicin: A useful tool for understanding proteosome biology, Bioorg. Med. Chem. Lett., 9, 2283, 10.1016/S0960-894X(99)00376-5
Rateb, 2011, Secondary metabolites of fungi from marine habitats, Nat. Prod. Rep., 28, 290, 10.1039/c0np00061b
Imhoff, 2011, Bio-mining the microbial treasures of the ocean: New natural products, Biotechnol. Adv., 29, 468, 10.1016/j.biotechadv.2011.03.001